科研之友ScholarMate
免费注册
首页 论文 论文详情
赞 收藏 引用

A phase I dose escalation study of hPV19, a novel humanized monoclonal antibody against vascular endothelial growth factor (VEGF), in patients with advanced solid tumors refractory to standard therapy.

作者：Dongmei, Ji; Weina, Shen; Hongzhen, Li; Yan, Xia; Yu, Wang; Shiping, Luo; Qunmin, Zhou; Yiqing, Xu; Junning, Cao
来源：Journal of Clinical Oncology, 2018, 36(15_suppl): 2522-2522.
DOI：10.1200/jco.2018.36.15_suppl.2522

全文

全文

访问全文
收藏 分享 被引 浏览
更新时间：2021-03-19 03:04